Viking Therapeutics (NASDAQ:VKTX) Releases Earnings Results, Beats Expectations By $0.02 EPS

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.02, Briefing.com reports. Viking Therapeutics’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period […]

Related Keywords

Charlesa Rowland Jr ,Raymond James ,Sei Investments Co ,Envestnet Asset Management Inc ,Therapeutics Company Profile ,Boothbay Fund Management ,Securities Exchange Commission ,Advisor Group Holdings Inc ,Cetera Advisor Networks ,Therapeutics Inc ,Viking Therapeutics ,Get Free Report ,Director Charles ,Exchange Commission ,Group Holdings ,Asset Management ,Fund Management ,Advisor Networks ,Viking Therapeutics Daily ,Nasdaq Vktx ,Vktx ,Medical ,Earnings ,